For achieving oxygen homeostasis through restoration of mitochondrial membrane potential and function in conditions associated with mitochondrial dysfunction, we have experimentally and clinically evaluated a novel phospholipid fraction designated NT factor. In Fisher 344 male rats, NT factor significantly improved mitochondrial membrane potential and decreased age-related hearing loss (3). In human subjects with disabling fatigue, the use of NT factor improved mitochondria membrane potential (as measured by rhodamine transport in leukocytes) and reduced clinical symptomatology. (4) The data obtained with the last three studies will be presented, and questions raised by the findings will be discussed.
1. Schriner SE, Linford NJ, Martin GM, et al. Extension of
urine life span by overexpression of catalase targeted to mitochondria.
ScienceExpress. www.scienceexpress.org/5May, 2005.
2. Ali M. Respiratory-to-Fermentative (RTF) Shift in ATP
Production in Chronic Energy Deficit States. Townsend Letter for Doctors and
Patients. 2004. August/Sept. issue. 64-65.
3. Seidman MD, Khan MJ, Tang WX, et al. Influence of lecithin
on mitochondrial DNA and age-related hearing loss. Otolaryngol Head Neck
Surgery. 2002;127:138-44.
4. Agajanyan M, Vasilevko V, Ghochikyan A, et al. Journal of
Chronic fatigue Syndrome. 2003;1:8-15.
Key words:
Problems or questions regarding this site should be directed to
the organiser